|
June 14, 2023
The HHS Office of Inspector General (OIG) is asking for participation by HRSA-funded health centers in an upcoming survey about substance use disorder (SUD) treatment.
What is the HHS OIG?
The OIG’s mission is to provide objective oversight to promote the economy, efficiency, effectiveness, and integrity of HHS programs as well as the health and welfare of the people served by these programs. They are charged with making recommendations for program improvements and ensuring access to care for program participants. OIG has a long-standing commitment to addressing the opioid overdose epidemic and has conducted several studies on access to SUD treatment.
Why are they conducting this study?
OIG is conducting a study examining the provision of SUD treatment at HRSA-funded health centers. They will survey a sample of 450 HRSA-funded health centers on issues related to medications for opioid use disorder, drug counseling, and mental health services. In addition, they will collect information on the barriers or successful strategies that impact the provision of these services. Visit their website for more information about this study (report expected in 2024) and OIG’s other work to improve access to SUD treatment.
What should you expect if your health center is selected?
If your health center is selected to participate, you will receive an email from healthsurveyinquiry@oig.hhs.gov with important information about completing the survey. Please make sure your voices and experiences are heard. Your responses are crucial to help OIG develop recommendations for program improvements and to ensure access to SUD treatment.
If you have questions, contact OIG at healthsurveyinquiry@oig.hhs.gov.
|
